Drugs / Oseltamivir Phosphate Capsules
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02989012 Comparator | ? → Jul 2019 | influenza | Dalian Zhen-Ao Bio-Tech Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oseltamivir Phosphate Capsules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02989012 ↗ |
| Route | Oral | “Oseltamivir Phosphate Capsules ,take oral” NCT02989012 ↗ |